Skip to main content
BGI Genomics Co., Ltd. logo

BGI Genomics Co., Ltd. — Investor Relations & Filings

Ticker · 300676 ISIN · CNE100003449 Shenzhen Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 1,656 across all filing types
Latest filing 2017-11-03 Proxy Solicitation & In…
Country CN China
Listing Shenzhen Stock Exchange 300676

About BGI Genomics Co., Ltd.

https://www.bgi.com

BGI Genomics Co., Ltd. is a leading provider of integrated solutions for precision medicine, specializing in genomic sequencing and proteomic services. The company offers a comprehensive portfolio of clinical diagnostics and research services across various fields, including reproductive health, oncology, and infectious diseases. Key products include non-invasive prenatal testing, hereditary cancer screening, and pathogen identification tools. Leveraging proprietary DNBseq sequencing technology, BGI Genomics provides high-throughput, cost-effective genomic data analysis to healthcare providers, research institutions, and pharmaceutical companies worldwide. The organization focuses on advancing personalized medicine through large-scale genomic research and the development of innovative diagnostic applications, aiming to improve health outcomes by making advanced genetic insights accessible to a global population.

Recent filings

Filing Released Lang Actions
关于召开2017年第三次临时股东大会的通知公告
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a detailed notice about the convening of the 2017 third extraordinary general meeting (临时股东大会) of Shenzhen BGI Genomics Co., Ltd. It includes information about the meeting date, time, location, agenda items, voting procedures, registration details, and attachments such as proxy forms and voting instructions. There is no financial data or report content, but rather a formal announcement and instructions related to a shareholders' meeting. This fits the definition of a Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings.
2017-11-03 Chinese
关于为董监高人员投保责任保险的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from Shenzhen BGI Genomics Co., Ltd. regarding the purchase of liability insurance for directors, supervisors, and senior management. It includes details about the insurance coverage, premiums, and the approval process, including opinions from independent directors and the supervisory board. The document is a formal announcement related to governance and risk management but does not contain financial statements, earnings data, or detailed management reports. It is not a report itself but an announcement of a corporate governance-related decision. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2017-11-03 Chinese
中信证券股份有限公司关于公司增加2017年度预计日常关联交易额度的核查意见
Audit Report / Information Classification · 95% confidence The document is a detailed verification opinion from CITIC Securities regarding Shenzhen BGI Genomics Co., Ltd.'s increase in the estimated daily related-party transaction quota for the year 2017. It includes extensive information about related-party transactions, pricing policies, financial data of related parties, and compliance with relevant laws and regulations. The document is not a full annual or interim financial report, nor is it a simple announcement or certification. It is a standalone audit or verification report focusing on related-party transactions and compliance, which fits the definition of an Audit Report / Information (AR). The document length (6077 characters) and content support this classification rather than a brief announcement or a full annual report. FY 2017
2017-11-03 Chinese
股票交易异常波动公告
Regulatory Filings Classification · 95% confidence The document is a stock trading abnormal fluctuation announcement by Shenzhen BGI Genomics Co., Ltd. It discusses unusual stock price movements over specific trading days and clarifies that no undisclosed material information exists that could have caused the fluctuation. It references the prior disclosure of the 2017 Q3 report but does not contain financial statements or detailed financial data itself. The document is short (1301 characters) and serves as a regulatory disclosure about stock price behavior rather than a financial report or earnings release. This fits the category of a Regulatory Filing (RNS), which covers miscellaneous regulatory announcements that do not fit other categories.
2017-10-31 Chinese
关于与康美药业股份有限公司签署战略合作协议的公告
Regulatory Filings Classification · 95% confidence The document is an announcement by Shenzhen BGI Genomics Co., Ltd. about signing a strategic cooperation agreement with Kangmei Pharmaceutical Co., Ltd. It details the nature of the agreement, the parties involved, the cooperation content, and the potential impact on the company. The document is relatively short (2612 characters) and does not contain any financial statements or detailed financial data. It is a disclosure of a corporate event (signing a strategic cooperation agreement) rather than a financial report or detailed management discussion. It does not fit into categories like Annual Report, Interim Report, or Earnings Release. It is not a regulatory certification or officer attestation. The document is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement about a corporate event that does not fit into more specific categories.
2017-10-31 Chinese
2017年第三季度报告披露提示性公告
Report Publication Announcement Classification · 95% confidence The document is a short announcement (435 characters) indicating that the company has disclosed its 2017 third quarter report on a regulatory website. It states the report was approved by the board and is available for investors to review. The text does not contain the actual financial data or detailed report content but serves as a notification of the report's publication. According to the 'MENU VS MEAL' rule, such a brief notice about the report's disclosure is classified as a Report Publication Announcement (RPA), not the report itself (IR).
2017-10-26 Chinese

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.